甲状腺眼病管理的区域差异:一项内分泌科医生国际临床实践调查的结果
该研究基于全球85个国家1252名内分泌科医生的在线调查,分析Graves病合并中重度甲状腺眼病(TED)诊疗的区域差异。结果显示初始诊断措施无区域差异,但亚硒酸钠使用在欧洲(66.5%)和大洋洲(60%)高于其他地区(p < 0.001),北美更推荐替妥木单抗且较少使用糖皮质激素(p < 0.001)。尽管存在区域差异,受访者总体遵循指南推荐,但也存在偏离现行指南的情况。
要点
- 中重度TED治疗中,欧洲(66.5%)和大洋洲(60%)使用亚硒酸钠的比例高于其他地区(p < 0.001)。
- 北美受访者更推荐替妥木单抗且更少使用糖皮质激素(p < 0.001)。
- 所有地区均首选长期使用抗甲状腺药物,但欧洲、北美和大洋洲更倾向于推荐甲状腺切除术(p < 0.001)。
核心结论
- 尽管存在区域差异,受访者总体采用现行临床实践指南推荐的诊断工具、治疗方法和多学科协作模式,但也存在偏离专业学会现行指南的情况。
研究设计与样本
- 一项全球在线调查,共纳入来自85个国家的1252名内分泌科医生,分析Graves病合并中重度甲状腺眼病诊疗的区域差异。
主要发现
- 关于初始诊断和治疗措施,不同地理区域之间无差异。
- 关于中重度TED的治疗,亚硒酸钠的使用在欧洲(66.5%)和大洋洲(60%)高于其他地区(p < 0.001)。
- 北美受访者更可能推荐替妥木单抗,且更不可能使用糖皮质激素(p < 0.001)。
- 比较合并TED的Graves病患者治疗选择时,尽管长期使用抗甲状腺药物在所有地区均为首选,但欧洲、北美和大洋洲的受访者比其他地区更可能推荐甲状腺切除术(p < 0.001)。
- 在北美、大洋洲和非洲,TED先进药物治疗更常由眼科医生而非内分泌科医生负责处方,而在全球其他地区则由内分泌科医生承担主要责任。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Over the past several decades, there have been indications of potential shifts in the diagnostic strategies and treatment of patients with Graves' disease (GD) and thyroid eye disease (TED). The objective of this study was to evaluate current practices in managing GD when complicated by moderate-to-severe TED worldwide. Methods: We recently reported results from a global online survey of endocrinologists comparing the management of GD in different scenarios. The current analysis focuses on regional differences in the diagnosis and treatment of GD when complicated by TED. Results: A total of 1252 respondents from 85 countries completed the survey. Regarding the initial diagnostic and treatment measures, there were no differences among the various geographical regions. Regarding the treatment of moderate-to-severe TED, the use of sodium selenite was higher in Europe (66.5%) and Oceania (60%) compared to other regions (p < 0.001). North American respondents were more likely to recommend teprotumumab and less likely to use glucocorticoids (p < 0.001). When comparing the treatment options for GD in patients with TED, although prolonged use of antithyroid drugs (ATD) remained the first choice in all regions, respondents from Europe, North America, and Oceania were more likely to recommend thyroidectomy than those from other regions (p < 0.001). Ophthalmologists, rather than endocrinologists, would more often be responsible for prescribing advanced medical therapy for TED in North America, Oceania, and Africa, while endocrinologists would have primary responsibility in other regions of the globe. Conclusions: Although there are regional differences, respondents generally employ the recommended diagnostic tools, treatments, and a multidisciplinary approach suggested by current clinical practice guidelines. However, there were examples of deviations from current guidance from professional societies.
引用
- Villagelin D, Cooper DS, Burch HB, et al. Regional Differences in the Management of Thyroid Eye Disease: Results from an International Clinical Practice Survey of Endocrinologists. Thyroid. 2025. PMID: 40432588. doi:10.1089/thy.2024.0759
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。